n.a. Finance cost (290.7) (200.8) 44.7% (281.2) 3.4% Share of profit/loss from JVs/associates (equity income) (430.4) 284.1 n.a. (238.4) (80.5%) Reported Net Profit/(Loss) (1,213.1) 390.3 n.a. (806.6
revenue 750.37 852.18 -101.81 -12.0% 1,475.45 1,710.98 -235.53 -13.8% Cost of goods sold & service 658.94 741.76 -82.82 -11.2% 1,297.29 1,485.01 -187.72 -12.6% Selling expenses 17.89 16.73 1.16 6.9% 33.40
+ 𝛾8𝑆𝐴𝐿𝐸𝑆𝑖𝑡 + 𝛾9𝑆𝐴𝐿𝐸𝑆𝑉𝐴𝑅𝑖𝑡 + 𝜀𝑖𝑡 (6) where 𝑅𝐷𝑖𝑡 is research and development expense scaled by a lagged market value of equity. 𝐶𝐴𝑃𝐸𝑋𝑖𝑡 is capital expenditure scaled by lagged market
2204 2601 โทรสำร 0 2204 2616 191/43 CTI Tower 21st Floor, Ratchadapisek Road, Klongtoey Subdistrict, Klongtoey District, Bangkok 10110 Tel. 0 2204 2601 Fax. 0 2204 2616 Progress of major debtors which is
372.36 20.73 35.11 Loss from impairment of investment in associate 107.78 783.85 65.33 110.64 Management benefit expenses 18.68 135.86 24.06 40.75 Financial cost 0.69 5.02 0.41 0.69 Share of losses in
in interest income on investment in loans by 51.3%, due to a high base in 2016 from loan restructuring progress of large accounts. Interest income from hire purchase and financial lease declined by 1.4
in interest income on investment in loans by 51.3%, due to a high base in 2016 from loan restructuring progress of large accounts. Interest income from hire purchase and financial lease declined by 1.4
. amount Baht 3.09 million. The other income went down 18.48% amount to Baht 5.00 million. 2. The cost of medical treatments when compared to income from medical treatments decreased 2.56% due to the cost of
Suit Co.,Ltd. amount Baht 10.17 million. The other income went up 19.47% amount to Baht 4.38 million. 2. The cost of medical treatments when compared to income from medical treatments increased 1.11% due
and targeted to lead to $350 million in run-rate cost savings by 2023. These initiatives and the strategic acquisition of the Huntsman Integrated Ethylene and Propylene Oxide (EO & PO) assets (code